110 related articles for article (PubMed ID: 20045207)
21. Recurrent in-stent restenosis is not associated with the angiotensin-converting enzyme D/I, angiotensinogen Thr174Met and Met235Thr, and the angiotensin-II receptor 1 A1166C polymorphism.
Gross CM; Perrot A; Geier C; Posch MG; Hassfeld S; Kramer J; Schmidt S; Derer W; Dietz R; Ozcelik C
J Invasive Cardiol; 2007 Jun; 19(6):261-4. PubMed ID: 17541127
[TBL] [Abstract][Full Text] [Related]
22. Low basal levels of circulating adiponectin in patients undergoing coronary stenting predict in-stent restenosis, independently of basal levels of inflammatory markers: lipoprotein associated phospholipase A2, and myeloperoxidase.
Moldoveanu E; Mut-Vitcu B; Tanaseanu GR; Marta DS; Manea G; Kosaka T; Vidulescu C; Tanaseanu C
Clin Biochem; 2008 Dec; 41(18):1429-33. PubMed ID: 18930040
[TBL] [Abstract][Full Text] [Related]
23. Late Restenosis After Paclitaxel-Coated Balloon Angioplasty Occurs in Patients With Drug-Eluting Stent Restenosis.
Habara S; Kadota K; Shimada T; Ohya M; Amano H; Izawa Y; Kubo S; Hyodo Y; Otsuru S; Hasegawa D; Tada T; Tanaka H; Fuku Y; Goto T; Mitsudo K
J Am Coll Cardiol; 2015 Jul; 66(1):14-22. PubMed ID: 26139053
[TBL] [Abstract][Full Text] [Related]
24. Immediate results and long-term clinical outcome of patients with unprotected distal left main restenosis: the CORPAL registry (Córdoba and Las Palmas).
Ojeda S; Pan M; Martín P; Mazuelos F; Suárez de Lezo J; Romero M; Segura J; Pavlovic D; Medina A; Suárez de Lezo J
JACC Cardiovasc Interv; 2014 Feb; 7(2):212-221. PubMed ID: 24440026
[TBL] [Abstract][Full Text] [Related]
25. Toll-like receptor 4 gene polymorphisms show no association with the risk of clinical or angiographic restenosis after percutaneous coronary intervention.
Beijk MA; Boekholdt SM; Rittersma SZ; Pons D; Zwinderman AH; Doevendans PA; Tio RA; Tijssen JG; Jukema JW; de Winter RJ
Pharmacogenet Genomics; 2010 Sep; 20(9):544-52. PubMed ID: 20671584
[TBL] [Abstract][Full Text] [Related]
26. The 5A6A polymorphism in the promoter of the stromelysin-1 (MMP3) gene as a risk factor for restenosis.
Humphries S; Bauters C; Meirhaeghe A; Luong L; Bertrand M; Amouyel P
Eur Heart J; 2002 May; 23(9):721-5. PubMed ID: 11977998
[TBL] [Abstract][Full Text] [Related]
27. High soluble Fas and soluble Fas Ligand serum levels before stent implantation are protective against restenosis.
Katsaros KM; Wiesbauer F; Speidl WS; Kastl SP; Huber K; Zorn G; Niessner A; Glogar D; Maurer G; Wojta J
Thromb Haemost; 2011 May; 105(5):883-91. PubMed ID: 21359408
[TBL] [Abstract][Full Text] [Related]
28. Angiographic patterns of restenosis after percutaneous intervention of chronic total occlusive lesions with drug-eluting stents.
Lee SP; Shin DH; Park KW; Kang HJ; Koo BK; Cho YS; Yeon TJ; Chae IH; Choi DJ; Kim HS
Int J Cardiol; 2012 Apr; 156(2):180-5. PubMed ID: 21109317
[TBL] [Abstract][Full Text] [Related]
29. Genetic markers of restenosis after coronary angioplasty and after stent implantation.
Petrovic D; Peterlin B
Med Sci Monit; 2005 Apr; 11(4):RA127-35. PubMed ID: 15795709
[TBL] [Abstract][Full Text] [Related]
30. Association of RAGE gene polymorphisms with in-stent restenosis in non-diabetic Korean population.
Shim CY; Park S; Yoon SJ; Park HY; Kim HT; Oh B; Park C; Ko YG; Choi D; Jang Y; Chung N
Cardiology; 2007; 107(4):261-8. PubMed ID: 16954682
[TBL] [Abstract][Full Text] [Related]
31. The microsatellite polymorphism of heme oxygenase-1 is associated with baseline plasma IL-6 level but not with restenosis after coronary in-stenting.
Li P; Elrayess MA; Gomma AH; Palmen J; Hawe E; Fox KM; Humphries SE
Chin Med J (Engl); 2005 Sep; 118(18):1525-32. PubMed ID: 16232329
[TBL] [Abstract][Full Text] [Related]
32. Implications of the "watermelon seeding" phenomenon during coronary interventions for in-stent restenosis.
Alfonso F; Pérez-Vizcayno MJ; Gómez-Recio M; Insa L; Calvo I; Hernández JM; Bullones JA; Hernández R; Escaned J; Macaya C; Gama-Ribeiro V; Leitao-Marques A;
Catheter Cardiovasc Interv; 2005 Dec; 66(4):521-7. PubMed ID: 16261546
[TBL] [Abstract][Full Text] [Related]
33. Association of the Endothelial Nitric Oxide Synthase Gene T786C Polymorphism with In-Stent Restenosis in Chinese Han Patients with Coronary Artery Disease Treated with Drug-Eluting Stent.
Zeng WP; Zhang R; Li R; Luo JF; Hu XF
PLoS One; 2017; 12(1):e0170964. PubMed ID: 28129392
[TBL] [Abstract][Full Text] [Related]
34. Optical coherence tomography (OCT) in PCI for in-stent restenosis (ISR): rationale and design of the SEDUCE (Safety and Efficacy of a Drug elUting balloon in Coronary artery rEstenosis) study.
Adriaenssens T; Dens J; Ughi G; Coosemans M; Onsea K; Dubois C; Sinnaeve P; Vrolix M; Desmet W
EuroIntervention; 2011 May; 7 Suppl K():K100-5. PubMed ID: 22027717
[TBL] [Abstract][Full Text] [Related]
35. Endothelial vasomotor dysfunction in the brachial artery is associated with late in-stent coronary restenosis.
Kitta Y; Nakamura T; Kodama Y; Takano H; Umetani K; Fujioka D; Saito Y; Kawabata K; Obata JE; Ichigi Y; Mende A; Kugiyama K
J Am Coll Cardiol; 2005 Aug; 46(4):648-55. PubMed ID: 16098430
[TBL] [Abstract][Full Text] [Related]
36. Impact of coronary collateral circulation on angiographic in-stent restenosis in patients with stable coronary artery disease and chronic total occlusion.
Yang ZK; Shen Y; Hu J; Zhang Q; Ding FH; Zhang RY; Lu L; Shen WF
Int J Cardiol; 2017 Jan; 227():485-489. PubMed ID: 27836292
[TBL] [Abstract][Full Text] [Related]
37. Interleukin 8 gene polymorphisms and susceptibility to restenosis after percutaneous coronary intervention.
Vogiatzi K; Apostolakis S; Voudris V; Thomopoulou S; Kochiadakis GE; Spandidos DA
J Thromb Thrombolysis; 2010 Jan; 29(1):134-40. PubMed ID: 19404719
[TBL] [Abstract][Full Text] [Related]
38. Stent thrombosis: nightmare of the interventional cardiology era.
Karakurt O; Akdemir R
Int J Cardiol; 2011 May; 148(3):e51-2. PubMed ID: 19285352
[TBL] [Abstract][Full Text] [Related]
39. Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis: the three-year results of the PEPCAD II ISR study.
Unverdorben M; Vallbracht C; Cremers B; Heuer H; Hengstenberg C; Maikowski C; Werner GS; Antoni D; Kleber FX; Bocksch W; Leschke M; Ackermann H; Boxberger M; Speck U; Degenhardt R; Scheller B
EuroIntervention; 2015 Dec; 11(8):926-34. PubMed ID: 25169589
[TBL] [Abstract][Full Text] [Related]
40. The combined use of Drug-eluting balloon and Excimer laser for coronary artery Restenosis In-Stent Treatment: The DERIST study.
Ambrosini V; Golino L; Niccoli G; Roberto M; Lisanti P; Ceravolo R; Bernardi G; Armigliato P; Gabrielli G; Chizzola G; De Paulis C; Crea F; Colombo A
Cardiovasc Revasc Med; 2017; 18(3):165-168. PubMed ID: 28081977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
